The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognizes that field of nuclear medicine and molecular imaging is changing rapidly. In 2017, with the vision of Satoshi Minoshima, MD, PhD, then SNMMI President, with support by Virginia Pappas, CAE, SNMMI CEO, launched the SNMMI Value Initiative.
The new Minoshima-Pappas Transformative Leadership Award will recognize an individual who has made transformative impact in the field and elevated the value of nuclear medicine and molecular imaging. Award recipients must have initiated, developed, and successfully implemented unique and significant transformative value within the field of Nuclear Medicine and Molecular Imaging.
Examples include high impact discovery and publication that have changed patient care, initiation of multi-national collaborative research, revolutionizing education methods, practice changing quality management, regulatory and/or legislative transformations, innovative outreach to patients and other stakeholders..
No results returned.